Top Journalists
>
Keith Speights

Keith Speights

Contributing Writer at The Motley Fool

Contact this person
Email address
k*****@*******.comGet email address
Influence score
70
Phone
(XXX) XXX-XXXXGet mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine
  • Finance & Banking Services

View more media outlets and journalists by signing up to AI PR

View latest data and reach out all from one place
Sign up to AI PR Toolkit

Recent Articles

fool.com

Worried About an AI Bubble? This ETF Could Be the Smartest Buy Right Now

This ETF offers a smart middle ground for investors anxious about the AI trade but who don't want to sit on the sidelines.
fool.com

SpaceX Stock Is 25% Below Its All-Time High. Here’s What $5,000 Inv...

SpaceX could be a big winner or a big loser for investors by the end of next year.
fool.com

Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Bett...

Both of these biotech stocks could be appealing to income investors.
fool.com

Prediction: Here’s Where SpaceX Stock Will Trade on Its 1-Year IPO ...

SpaceX made IPO history in June. But how will its stock perform one year later?
fool.com

Alnylam Is Now Solidly Profitable. Why Are Investors Treating It Li...

This beaten-down biotech has a better story than its stock chart suggests.
fool.com

If a Stock Market Crash Is Coming, History Says This 1 Strategy Has...

This highly effective investing approach is both simple and counterintuitive.
fool.com

Here’s the Hands-Down Best Cannabis Stock for Dividend Investors

Aggressive income investors could love this stock.
fool.com

3 High-Yield Energy Stocks to Load Up on This October (1 Yields Ove...

These pipeline stocks are income investors' dreams.
fool.com

If a Stock Market Crash Is Coming, History Says These 3 ETFs Are th...

These funds can help you weather any storm that might be on the way.
fool.com

The Stock Market Is Making a Move That Warren Buffett Has Warned Ab...

Maybe history won't repeat itself this time around. But maybe it will.
fool.com

Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotec...

Is bigger always better? Not necessarily.